Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population
Status:
Completed
Trial end date:
2020-04-28
Target enrollment:
Participant gender:
Summary
This is a single-arm phase II trial to assess the biological activity (in a sub-cohort using
a Simon two-stage Phase II design) and toxicity of Artichoke Whole Phytocomplex Concentrate
(WPC). The objective of the study is to explore the potential for a non-toxic phytocomplex
extract from the artichoke plant as a chemoprevention agent.